Hangzhou Nutrition Biotechnology Co., Ltd. CB
Hangzhou Nutrition Biotechnology Co., Ltd. CB is a Chinese biotechnical enterprise located in Hangzhou, with operations focused on the production of collagen-related products and enteral nutrition solutions. The company has built its activities around the development, manufacture, and supply of bulk hydrolyzed collagen powders, fish collagen peptides, collagen granules, and various enteral nutrition formulations. Its product portfolio includes nutrition powders such as mixed branched-chain amino acid formulas, dietary fiber blends, and multiple vitamin formulations, reflecting a broad approach to support nutritional and medical needs.
Founded in 2009, Hangzhou Nutrition Biotechnology Co., Ltd. CB has established itself through an emphasis on research and development, complemented by a structured manufacturing capability. The firm highlights the presence of its own production workshops dedicated to collagen and related products, enabling a controlled production environment and consistent output. The company discontinued or rebranded as needed to reflect its scope of operations but maintains a steady emphasis on product quality and scientific development.
A notable development cited by the company is the support from the Zhejiang Province government in 2012 for a key technology related to fish collagen peptide production. This backing illustrates a degree of governmental and academic collaboration to advance its collagen-related innovations. The organization maintains a multi-facility footprint (workshops) within its Hangzhou base, signaling an integrated supply chain to manage both bulk raw materials and finished products for the market.
Quality and safety management are core to Hangzhou Nutrition Biotechnology Co., Ltd. CB’s operations are aligned with internationally recognized and regionally relevant standards. The company reports compliance with QS (Quality Safety), HACCP (Hazard Analysis and Critical Control Points), ISO 22000 (Food Safety Management), HALAL standards, and CIQ (China Inspection and Quarantine) accreditation. These certifications indicate a structured approach to quality control, traceability, and food and pharmaceutical-grade production processes, which are essential for products intended for medical and dietary use.
With a regional market focus that includes partnerships and product acceptance in major Chinese medical institutions, Hangzhou Nutrition Biotechnology Co., Ltd. CB has positioned itself to serve hospitals and clinics that require standardized, regulated nutrition products. Notable mentions of affiliations or collaborations with recognized medical institutions highlight the company’s aim to integrate into clinical settings where evidence-based nutrition supports patient care. The company reports a market share in medical foods, indicating active participation in a value chain that intersects with healthcare providers and patient nutrition programs.
In terms of capabilities, the organization emphasizes both the development of product formulations and the manufacture of finished goods in various formats. The OEM capacity mentioned suggests that Hangzhou Nutrition Biotechnology Co., Ltd. CB offers manufacturing and formulation support to other brands or healthcare providers seeking to develop or private-label collagen and nutrition products. The combination of internal R&D capabilities, regulatory certifications, and an established production base provides a framework for product development, quality assurance, and scalable production.
The company’s geographic footprint in Hangzhou places it within one of China’s prominent economic hubs, with proximity to major logistics corridors and port facilities that can facilitate both domestic distribution and potential export activities. This geographic positioning supports a practical approach to supply chain management, enabling efficient delivery of bulk materials and finished goods to customers within China and potentially beyond.
From a market perspective, Hangzhou Nutrition Biotechnology Co., Ltd. CB operates in sectors where collagen-based products and specialized enteral nutrition play a significant role in clinical nutrition, dietary supplements, and hospital-based nutrition programs. The organization’s emphasis on high-quality standards, paired with its long-standing presence since 2009, aligns with industry expectations for reliability and traceability in nutraceutical and medical-grade products.
Overall, Hangzhou Nutrition Biotechnology Co., Ltd. CB presents an organizational profile characterized by a focus on collagen and enteral nutrition product development and manufacturing, supported by formal quality systems, government-backed technological advancement, and a stated positioning within the medical nutrition landscape of China. The company’s ongoing emphasis on research and development, combined with its certification portfolio and manufacturing capabilities, suggests core competencies in product formulation, compliant production, and the potential for collaborative OEM engagements with healthcare providers and private-label partners.
